Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease

Status unconfirmed · Phase 4

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

To evaluate the magnitude of the humoral immune responses to quadrivalent vs trivalent influenza vaccines in adults between the age of 50 and 64 years with a prior diagnosis of GOLD Stage C and D COPD vs. those patients without COPD.

Key facts

Study ID
NCT02563184
Run by
Banner Health
People needed
100
Starts
2015-09-01
Expected to finish
2016-02-01
Last updated by the study team
2015-09-30

Who can join

Age: 50 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.